Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 25, 2018 16:05 ET | Source: MRI Interventions, Inc.

MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinson’s Disease

Initial Data Expected in First Half of 2019 IRVINE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Axovant Sciences Ltd. on the dosing of its first patient...
October 24, 2018 16:05 ET | Source: MRI Interventions, Inc.

MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe

IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic Laser Probe. The new probe replaces a...
October 19, 2018 07:30 ET | Source: MRI Interventions, Inc.

MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada

Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License...
October 17, 2018 10:24 ET | Source: MRI Interventions, Inc.; Clinical Laserthermia Systems AB

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery -- UPDATE

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 ...
October 17, 2018 07:30 ET | Source: MRI Interventions, Inc.; Clinical Laserthermia Systems AB

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 ...
October 12, 2018 08:30 ET | Source: MRI Interventions, Inc.

MRI Interventions and Monteris Medical Announce Collaboration to Develop Next-Generation Head Fixation Frames for Laser Ablation Neurosurgery

IRVINE, Calif., Oct. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) and Monteris Medical, Inc. today announced a collaborative co-development agreement to provide a...
September 25, 2018 17:16 ET | Source: MRI Interventions, Inc.

MRI Interventions Retires Brainlab Debt, Extends 2019 Notes by 18 Months

IRVINE, Calif. , Sept. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), announced today that the company has repaid in full and retired $2.0 million in outstanding debt held by...
September 12, 2018 07:30 ET | Source: MRI Interventions, Inc.

MRI Interventions to Present at Sidoti & Co. 2018 Fall Conference on Sept 27

LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall...
August 14, 2018 16:05 ET | Source: MRI Interventions, Inc.

MRI Interventions Reports Second Quarter Results

IRVINE, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results for its second fiscal quarter ended June 30, 2018. Second...
August 07, 2018 16:05 ET | Source: MRI Interventions, Inc.

MRI Interventions, Inc. to Announce Second Quarter 2018 Results on August 14

IRVINE, Calif., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 second quarter, which ended June 30, 2018, on...